Clinical trial
Emollient Therapy for Improved Survival and Growth of Very Low Birth Weight Infants in Zimbabwe
NCT05461404 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Emollient Therapy for Improved Survival and Growth of Very Low Birth Weight Infants in Zimbabwe
- Lead sponsor
- Stanford University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 520 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
very low birth weight infant